Investors

View Stock Information
Corporate presentation image
Corporate Presentation (PDF)

Corporate Profile

Sernova is a regenerative medicine company developing therapeutic technologies with multibillion-dollar market potential for each of its clinical indications.

Press Releases

March 10, 2025
Sernova Biotherapeutics Appoints Pericles Calias, Ph.D. as Chief Development Officer and Head of R&D
March 5, 2025
Sernova Biotherapeutics Secures $1 Million Convertible Debt Financing
March 3, 2025
Sernova Biotherapeutics Receives FDA Clearance for IND Application for its Cell Pouch Bio-hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism
View All Press Releases

Events

January 10, 2025
Annual General and Special Meeting of Shareholders
December 13, 2024 ET
Sernova Virtual Investor Event: Meet Our Leadership
View All Events

IR Contact


David Burke
Vice President, Investor Relations
917.751.5713
david.burke@sernova.com

Email Alerts Sign-Up

Scroll to Top